Abstract: A protocol chip transmits the request from the host apparatus to a first processor through a first address translation unit. A first processor transmits a response to the request from the host apparatus, to the protocol chip through the first address translation unit. When the first processor stops processing, an instruction to transmit the request from the host apparatus to a second processor is transmitted to the protocol chip. When receiving the instruction to transmit the request from the host apparatus to the second processor, the protocol chip transmits the request from the host apparatus to the second processor through a second address translation unit. The second processor transmits the response to the request from the host apparatus to the protocol chip through the second address translation unit.

Abstract: A multi-pattern build evaluation method according to the present disclosure includes acquiring, for each of a plurality of changed source codes, change information including information indicating a changed source code and synchronous element information indicating a synchronous element related between the changed source code and another changed source code, generating two or more packages including one or more pieces of the change information based on the synchronous element information between the plurality of changed source codes, and generating an overall build pattern including all of the two or more packages and partial build patterns including some of the two or more packages.

Abstract: A seat heater that is a seat including: a planer heating element that has a plurality of electric heating wires on its upper surface and that includes a fiber layer; a cushion member that locates over a lower surface of the planer heating element; and a skin that locates above the planer heating element, wherein the planer heating element has, in voids of the fiber layer, a silica aerogel that is a silica porous body having pores with a mean pore diameter of 10 nm to 68 nm.

Abstract: A composite sheet includes: a graphite layer that is disposed on a high temperature portion; an aerogel layer that is disposed on a low temperature portion; and an adhesive layer to which the graphite layer and the aerogel layer are fixed, in which the adhesive layer is formed of a water-based adhesive. The water-based adhesive layer is formed of an adhesive containing water as a solvent or an adhesive containing water as a raw material. The water-based adhesive layer includes gaps.

Abstract: Disclosed are methods of enhancing the chemotherapeutic treatment of tumor cells, reducing resistance of a cancer cell to a chemotherapeutic agent, a method of inhibiting ABCG2, Pgp, or MRP1 in a mammal afflicted with cancer, and a method of increasing the bioavailability of an ABCG2 substrate drug in a mammal. The methods comprise administering effective amounts of certain compounds to the mammal, for example, a compound of the formula (I): wherein R1, R2, R3, X1, X2, X3, a, and b are as described herein. Uses of these compounds in the preparation of a medicament are also disclosed. Also disclosed are compounds of formula (II), pharmaceutical compositions comprising such compounds and uses thereof.

Abstract: A seat heater that is a seat including: a planer heating element that has a plurality of electric heating wires on its upper surface and that includes a fiber layer; a cushion member that locates over a lower surface of the planer heating element; and a skin that locates above the planer heating element, wherein the planer heating element has, in voids of the fiber layer, a silica aerogel that is a silica porous body having pores with a mean pore diameter of 10 nm to 68 nm.

Abstract: A composite sheet includes: a graphite layer that is disposed on a high temperature portion; an aerogel layer that is disposed on a low temperature portion; and an adhesive layer to which the graphite layer and the aerogel layer are fixed, in which the adhesive layer is formed of a water-based adhesive. The water-based adhesive layer is formed of an adhesive containing water as a solvent or an adhesive containing water as a raw material. The water-based adhesive layer includes gaps.

Abstract: A steel used in a belt-type CVT that is superior in wear resistance and toughness, and a steel for cold punching, that provides the same. The steel satisfies the following: 10.8 [C]+5.6 [Si]+2.7 [Mn]+0.3 [Cr]+7.8 [Mo]+1.4 [V]?13. The steel contains C within the range of 0.50 to 0.70%, Si within the range of 0.03 to 0.60%, Mn within the range of 0.50 to 1.00%, Cr within the range of 0.20 to 1.00%, Ti within the range of 0.01 to 0.10%, and B within the range of 0.0005 to 0.0050% by mass as required additional elements, P within the range of 0.025% or less and S within the range of 0.015% or less by mass as optional additional elements, and the remainder as Fe and unavoidable impurities.

Abstract: Disclosed are methods of enhancing the chemotherapeutic treatment of tumor cells, reducing resistance of a cancer cell to a chemotherapeutic agent, a method of inhibiting ABCG2, Pgp, or MRP1 in a mammal afflicted with cancer, and a method of increasing the bioavailability of an ABCG2 substrate drug in a mammal. The methods comprise administering effective amounts of certain compounds to the mammal, for example, a compound of the formula (I): wherein R1, R2, R3, X1, X2, X3, a, and b are as described herein. Uses of these compounds in the preparation of a medicament are also disclosed. Also disclosed are compounds of formula (II), pharmaceutical compositions comprising such compounds and uses thereof.

Abstract: Disclosed are methods of enhancing the chemotherapeutic treatment of tumor cells, reducing resistance of a cancer cell to a chemotherapeutic agent, a method of inhibiting ABCG2, Pgp, or MRP1 in a mammal afflicted with cancer, and a method of increasing the bioavailability of an ABCG2 substrate drug in a mammal. The methods comprise administering effective amounts of certain compounds to the mammal, for example, a compound of the formula (I): Formula (I), wherein R1, R2, R3, X1, X2, X3, a, and b are as described herein. Uses of these compounds in the preparation of a medicament are also disclosed. Also disclosed are compounds of formula (II), pharmaceutical compositions comprising such compounds and uses thereof.

Abstract: A non-heat treated connecting rod which comprises, by mass %, C: 0.25-0.35%, Si: 0.50-0.70%, Mn: 0.60-0.90%, P: 0.040-0.070%, S: 0.040-0.130%, Cr: 0.10-0.20%, V: 0.15-0.20%, Ti: 0.15-0.20% and N: 0.002-0.020%, and the balance Fe and impurities, with chemical compositions being less than 0.80 in the value of C+(Si/10)+(Mn/5)+(5Cr/22)+1.65 V?(5S/7) using the symbol of the element as its content, the microstructure of the Big end of the said connecting rod being ferrite-pearlite, all-region hardness of the said big end being 255 to 320 in Vickers hardness, the ferrite-region hardness in the said ferrite-pearlite of the Big end being 250 or more in Vickers hardness and the ratio of the said ferrite-region hardness to the said all-region hardness of the said Big end being 0.80 or more, is excellent in machinability, fracture splitting ability, and fatigue resistance, although no Pb at all is added.

Abstract: Disclosed are methods of enhancing the chemotherapeutic treatment of tumor cells, reducing resistance of a cancer cell to a chemotherapeutic agent, a method of inhibiting ABCG2, Pgp, or MRP1 in a mammal afflicted with cancer, and a method of increasing the bioavailability of an ABCG2 substrate drug in a mammal. The methods comprise administering effective amounts of certain compounds to the mammal, for example, a compound of the formula (I): Formula (I), wherein R1, R2, R3, X1, X2, X3, a, and b are as described herein. Uses of these compounds in the preparation of a medicament are also disclosed. Also disclosed are compounds of formula (II), pharmaceutical compositions comprising such compounds and uses thereof.

Abstract: A member produced by powder forging which retains machinability and improved fatigue strength without having an increased hardness and can retain self conformability after fracture splitting; a powder mixture for powder forging; a process for producing a member by powder forging; and a fracture splitting connecting rod obtained from the member produced by powder forging. The member produced by powder forging is one obtained by preforming a powder mixture, subsequently sintering the preform, and forging the resultant sintered preform at a high temperature. The free-copper proportion in the sintered preform at the time when the forging is started is 10% or lower, and the member obtained through the forging has a composition containing, in terms of mass %, 0.2-0.4% C, 3-5% Cu, and up to 0.4% Mn (excluding 0), the remainder being iron and incidental impurities, and has a ferrite content of 40-90%.

Abstract: Disclosed is a high-strength bolt having a tensile strength of 1,200 N/mm2 or more and superior in delayed fracture resistance and relaxation resistance, prepared by wire-drawing a bolt steel containing the following elements: C: 0.5 to 1.0% (mass %, the same shall apply hereinafter), Si: 0.55 to 3%, Mn: 0.2 to 2%, P: 0.03% or less (but not 0%), S: 0.03% or less (but not 0%), and Al: 0.3% or less (but not 0%), and containing proeutectoid ferrite, proeutectoid cementite, bainite and martensite at a total areal rate of less than 20% and pearlite in balance; cold-heading the wire into a bolt shape; and then bluing the bolt in a temperature range of 100 to 500° C.

Abstract: A non-heat treated connecting rod which comprises, by mass %, C: 0.25-0.35%, Si: 0.50-0.70%, Mn: 0.60-0.90%, P: 0.040-0.070%, S: 0.040-0.130%, Cr: 0.10-0.20%, V: 0.15-0.20%, Ti: 0.15-0.20% and N: 0.002-0.020%, and the balance Fe and impurities, with chemical compositions being less than 0.80 in the value of C+(Si/10)+(Mn/5)+(5Cr/22)+1.65 V?(5S/7) using the symbol of the element as its content, the microstructure of the Big end of the said connecting rod being ferrite-pearlite, all-region hardness of the said big end being 255 to 320 in Vickers hardness, the ferrite-region hardness in the said ferrite-pearlite of the Big end being 250 or more in Vickers hardness and the ratio of the said ferrite-region hardness to the said all-region hardness of the said Big end being 0.80 or more, is excellent in machinability, fracture splitting ability, and fatigue resistance, although no Pb at all is added.